Introduction {#S0001}
============

One of the important cardiac diseases with poor prognosis is congestive heart failure (CHF). In recent years it has become one of the most important public health problems in cardiovascular medicine.[@CIT0001] Despite effective improvement in therapeutics during the past two decades, CHF remains a major cause of cardiovascular morbidity and mortality. Aging of the population and survival improvement of patients with cardiovascular disease (CVD) by modern therapeutic innovations has led to the increasing prevalence of CHF.[@CIT0002]--[@CIT0004]

Since 1980, many studies have been reported a progressive improvement in the survival of CHF patients.[@CIT0005] However, the average survival remained poor after hospitalization for the first episode of or decompensated CHF.[@CIT0005], [@CIT0006] Mortality rate have increased after CHF hospitalization, even after adjustment for baseline predictors of death .[@CIT0007] The increased risk of death was highest within one month of discharge and declined progressively over time.[@CIT0006]

Despite the available data on other CVD, There are few data regarding CHF mortality and morbidity in Iran. Determining predicting factors that one related to mortality and morbidity of hospitalized decompensated CHF patients may help identify which patients need intensive monitoring during hospitalization and after discharge.

So, the aim of this study was to determine the predictors of 6-months survival in patients hospitalized for decompensated CHF in Isfahan.

Materials and Methods {#S0002}
=====================

Data collection {#S20003}
---------------

This cohort included 301 patients, hospitalized for decompensated CHF in two referral hospital for cardiac patients. As there two referral centers sample was representative of the patient\'s community. The diagnosis was done based on Framingham criteria of CHF by a cardiologist[@CIT0006], [@CIT0008]. Acute decompensation of CHF was defined by the presence of an acute increase of shortness of breath, pulmonary rales, vascular enlargement and/or frank edema detected by chest X-ray at the time of admission[@CIT0009], [@CIT0010]. At first a questionnaire was filled including demographics (sex, age, educational level, marital status and smoking (cigarette and /or opium history), medications such as (angiotensin converting enzyme (ACE) inhibitors, diuretics, beta blockers and other drugs). The history of diabetes mellitus (DM), myocardial infarction (MI), chronic obstructive pulmonary disease (COPD), renal disease and hypertension (HTN) were recorded.

Each patient underwent an echocardiography by a cardiologist. A thorough two-dimensional and Doppler echocardiographic study was performed according to a standard imaging protocol. Ejection fraction (EF) was determined. All measurement was done by VIVID 3 echocardiography machine, manufactured in 2006, General Electric Company. EF more or less than 50% was considered normal or low[@CIT0011]. Blood pressure was taken by standard protocol at the time of echocardiography[@CIT0012].

After discharge, patients were followed up for 6 months by telephone calls. Survival status was assessed by telephone contact with family members and verified by studying hospital records. At the end of the follow-up period, the collected data were subjected to statistical analysis.

Statistical analysis {#S20004}
--------------------

At the first step, data were described in tables and shown with central and distributional statistical indices. Then, survival analysis was done. Survival curves were plotted and stratified by EF groups using the Kaplan Meier method. The log-rank test was used to test for differences between the survival curves. Cox proportional hazards model was used for multivariate analysis. Statistical analyses were performed via SPSS for Windows, version 15; (SPSS Inc., Chicago, IL). Parametric data are presented as mean±SD or mean±SEM.

P value \<0.05 was considered statistically significant.

Ethical issues {#S20005}
--------------

The study was approved by the Ethics Committee in Isfahan Cardiovascular Research Center, WHO- Collaborating Center for Research and Training in Cardiovascular Diseases Control.

Results {#S0006}
=======

We recruited 301 patients aged 19-92 years old,with decompensated CHF who were admitted to the cardiology departments in two referral hospital. The baseline characteristics of studied patients have been shown in [table 1](#T0001){ref-type="table"}. Mean age of studied patients was 71.9±12.2.

###### 

Baseline characteristics of CHF patients

  Variable                                 Frequency    \%       
  ---------------------------------------- ------------ -------- --------
  Sex                                      Male         *180*    *59.8*
  Female                                   *121*        *40.2*   
  Age (years)                              \<65         *80*     *26.6*
  ≥65                                      *221*        *73.4*   
  Marital Status                           Single       *35*     *11.6*
  Married                                  *266*        *88.4*   
  Education                                Illiterate   *115*    *38.2*
  Primary school                           *94*         *31.2*   
  Intermediate school                      *3*          *1*      
  Diploma                                  *81*         *26.9*   
  Above diploma                            *8*          *2.7*    
  Current Smoker                           No           *262*    *87*
  Yes                                      *39*         *13*     
  Opium Addict                             No           *290*    *96.3*
  Yes                                      *11*         *3.7*    
  Diabetes Mellitus                        No           *192*    *63.8*
  Yes                                      *109*        *36.2*   
  Hypertension                             No           *162*    *53.8*
  Yes                                      *139*        *46.2*   
  Myocardial Infraction                    No           *241*    *80.1*
  Yes                                      *60*         *19.9*   
  Cerebrovascular Accident                 No           *273*    *90.7*
  Yes                                      *27*         *9.3*    
  COPD[\*](#TF0001){ref-type="table-fn"}   No           *264*    *87.7*
  Yes                                      *37*         *12.3*   
  Renal Diseases                           No           *273*    *90.7*
  Yes                                      *28*         *9.3*    

Chronic Obstrutive Pulmonary Disease

During hospitalization, normal and low EF were seen in 43 (14.3%) and 258 (85.7%) of patients, respectively. Mean level of EF was 29.5%±14.5. Most of patients were on medication and ACE inhibitors and diuretics were the major drugs which were used by patients ([Table 2](#T0002){ref-type="table"}).

###### 

Frequency of medication use in patients

  Drug                                     Number   Frequency %   
  ---------------------------------------- -------- ------------- ------
  ACEI[\*](#TF0002){ref-type="table-fn"}   No       79            26.2
  Yes                                      222      73.7          
  Diuretics                                No       49            16.3
  Yes                                      252      83.7          
  Beta blocker                             No       233           77.4
  Yes                                      68       22.6          
  Other medication                         No       44            14.6
  Yes                                      257      85.4          

Angiotensin Converting Enzyme Inhibitors

During 6-months follow-up 45.8% (138) of patients died. Mean survival was 119.2±4.4 days (Mean±SEM). We compared the survival between patients with normal and low EF. Kaplan-Meier analysis with log rank test did not show any significant differences between two groups ([Figure 1](#F0001){ref-type="fig"}).

![Survival of hospitalized decompensated CHF patients with normal and low EF](ARYA-6-112-g001){#F0001}

For determining the different groups of prognostic factors on survival of patients with CHF, three multivariate models of Cox' regressions were run. The first model was done on socio-demographic variables (Sex, age, education, marital status, and smoking habits). The second model was based on co-morbid diseases like HTN, DM, MI, CVA, COPD, and renal disease. The third hazard model was selected on the drug prescription. The predictive value as hazard ratio were obtained and shown in [table 3](#T0003){ref-type="table"}.

###### 

Independent predictors of 6-months survival of hospitalized decompensated CHF patients

                                             Predictors                              Hazard Ratio    95% CI          P value
  ------------------------------------------ --------------------------------------- --------------- --------------- -----------------------------------------
  Model 1                                    Sex (female)                            *1.03*          *0.72---1.48*   *N.S[\*](#TF0003){ref-type="table-fn"}*
  Age ≥65 years                              *1.58*                                  *0.81---3.07*   *N.S*           
  Education                                  *0.74*                                  *0.59---0.93*   *0.01*          
  Marital Status (married)                   *0.69*                                  *0.39---1.22*   *N.S*           
  Current smoker                             *1.12*                                  *0.64---1.94*   *N.S*           
  Opium addict                               *0.71*                                  *0.30---1.68*   *N.S*           
  Model 2                                    Diabetes Mellitus                       *1.22*          *0.85---1.78*   *N.S*
  Hypertension                               *0.69*                                  *0.48---1*      *N.S*           
  COPD[\*\*](#TF0004){ref-type="table-fn"}   *1.91*                                  *1.20---3.04*   *0.007*         
  Myocardial infarction                      *1.17*                                  *0.78---1.76*   *N.S*           
  Cerebrovascular accident                   *1.69*                                  *1.03---2.78*   *0.037*         
  Renal Disease                              *1.13*                                  *0.65---1.98*   *N.S*           
  Model 3                                    ACEI[¶](#TF0005){ref-type="table-fn"}   *0.44*          *0.30---0.66*   *\<0.001*
  Diuretics                                  *0.63*                                  *0.41---0.96*   *0.03*          
  Beta Blockers                              *0.77*                                  *0.49---1.21*   *N.S*           
  Other Medications                          *1.59*                                  *0.91---2.78*   *N.S*           

Non significant

Chronic Obstrutive Pulmonary Disease

Angiotensin Converting Enzyme Inhibitors

Discussion {#S0007}
==========

Our study provides a 6-month follow-up of a cohort of patients with CHF who were admitted in two referral hospitals in Isfahan city. In this study, we present prognostic factors regarding the survival of these patients.

Mortality of CHF during the 6-month follow-up was 45.8%. Previous study reported a mortality rate of 22% during 6-month follow-up in their study in 2005[@CIT0013]. However, other studies showed different mortality rate of 2% after one year follow-up[@CIT0014]. Another study from Denmark presented 54% death rate[@CIT0015]. On the other hand, a study in Spain demonstrated death rate of CHF to be 66.3%[@CIT0005]. The follow-up period in both studies was 5 years[@CIT0005], [@CIT0015]. The death rate of decompensated hospitalized CHF patients after 6-months follow-up was very high in our study. It seems that it depends on factors such as medical care and new technology, etiology of CHF, EF level and socioeconomic factors. Moreover, different case selection and definitions, or ethno-racial differences many lead to various results between studies. In our study we recruited hospitalized decompensated CHF patients.

One of prognostic factor on CHF is EF. However, nearly, 14% of our patients had a normal EF and their outcome regarding mortality and morbidity was severe as in patients with reduced EF[@CIT0016]. Some studies have showed that EF alone is not a predictive factor for CHF Prognosis[@CIT0017] whereas other echocardiographic findings like diastolic dysfunction and left ventricular hypertrophy play important roles in prognosis of CHF patients[@CIT0017]. In our study, there was no significant difference between the survival of CHF patients with normal EF and reduced EF that may be due to other variables that we did not include in the study.

Multivariate analysis in the current study demonstrated that comorbid diseases like COPD and CVA were prognostic factors for mortality in CHF patients. In contrast, high educational level and prescription of ACEIs and diuretics play protective role in the survival of CHF patients.

Although it has been reported that some factors such as comorbid diseases, anemia, some biochemical markers, hyperlipidemia, cardiac function and markers of physical performance affect the survival of CHF patients, [@CIT0018], but in our study, we could not study all factors. Another reason for the difference between our and other reports is the diversity in the prognosis of CHF, depending on the methods used for diagnostic purposes, the study design, and the underlying diseases. Investigations about CHF have been done in various distinct populations that include outpatients[@CIT0019]--[@CIT0021], inpatients hospitalized for disorders other than CHF[@CIT0022], in patients with new onset CHF[@CIT0023] or patients hospitalized for worsened CHF.[@CIT0010], [@CIT0024]--[@CIT0026]

We had some limitations in our study. We did not assess biochemical markers related to CHF. Furthermore, the underlying disease of CHF of our patients was not determined.

Conclusion {#S0008}
==========

According to our results, the 6 months prognosis of our hospitalized patients for decompensated CHF was poor. As higher education level had favorable prognostic impact on the survival, actions to improve the patient\'s awareness and training regarding these diseases may be effective. We also suggest careful investigation and better control of comorbid discovers to have better survival of CHF patients.
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